Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 73Colonic Neoplasms 14Rectal Neoplasms 13Neoplasm Metastasis 12Stomach Neoplasms 8Pancreatic Neoplasms 5Advanced Solid Tumors 5Neoplasms 4Colorectal Cancer Metastatic 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Carcinoma 3Adenocarcinoma 3Neutropenia 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Biliary Tract Neoplasms 2Bile Duct Neoplasms 2Advanced Solid Tumors (Excluding Breast Cancer) 2Advanced Colorectal Cancer 2Adenocarcinoma Of Esophagus 2mCRC 1Urologic Diseases 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Spinocerebellar Degenerations 1Solid Tumor Cancer 1Solid Tumor 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × trifluridine tipiracil drug combination × Clear all
NCT02301104 2024-09-05

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment

Taiho Oncology, Inc.

Phase 1 Completed
24 enrolled
Gastrointestinal

Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡